Selective gene expression in neurons is still a challenge. We have developed several expression vectors using a combination of neuron restrictive silencer elements (NRSEs), hypoxia responsive elements (HREs) and CMV minimal promoter (CMVmp). These elements were packaged into replication defective adenovirus to target gene expression selectively in neurons in a hypoxia-regulated manner. Neuronal selectivity and responsiveness to hypoxia of these novel constructs were determined empirically in both neural cell lines and primary cerebellar granule neurons (CGNs). The construct p5HRE-3NRSE exhibited not only the highest level of reporter gene expression in neuronal cells but also in an oxygen concentration-dependent manner when compared with all other constructs. As expected, this construct did not elicit reporter gene expression in non-neuronal cells including human HEK293A and HT29 cells, rat NRK cells, mouse 3T6 cells and 3T3 L1 cells. This construct was packaged into a replication defective adenoviral vector (Ad/5HRE-3NRSE) to determine neuron-selective and hypoxia-inducible gene expression in cultured mouse postmitotic primary CGNs and differentiated human NT2 neurons (NT2/Ns). Remarkably, in response to hypoxia, Ad/5HRE-3NRSE showed strong hypoxia-inducible gene expression selectively in neurons (12-fold induction in CGNs and 22-fold in NT2/Ns), but not in glial cells. Taken together, this vector with restricted gene expression to neurons under the regulation of hypoxia will be a useful tool for investigations of mechanisms of neuronal damage caused by ischemic insult.
Introduction
Viral vector-mediated gene therapy represents a promising approach to treat human neurological diseases. 1 Among the many gene delivery vectors, replication defective adenoviral vectors have been widely used as an effective tool to express therapeutic genes in the brains of rodent models of human neurological diseases including cerebral ischemia. [2] [3] [4] [5] [6] [7] [8] For example, adenoviral vector mediated expression of antiapoptotic genes, such as XIAP, 9,10 Bcl-2 11 or trophic factors, such as glial derived trophic factors, 12, 13 conferred potent neuroprotection against cerebral ischemia.
14 The characteristics of adenoviral vectors in terms of their low cytotoxicity, the ability to produce large quantities of viral particles, and the large cloning capacity has made adenovirus an excellent choice for development as a tool for gene transfer and therapy. [3] [4] [5] 8, 15 Adenoviruses contain a 36 kb double-stranded DNA genome packaged into an icosahedral capsid. Deletion of the E1 and E3 regions of the viral genome renders the adenovirus unable to selfreplicate and minimizes immunogenecity to the host cells, thereby reducing potential toxicity derived from the viral backbone. Replication-deficient adenoviral vectors are effective in transducing genes into both cycling and postmitotic cells including neurons. This high affinity to a broad spectrum of host cells makes adenovirus-mediated gene expression in the brain nondiscriminatory in cell type, which potentially produces undesired effects to the unintended cellular populations.
Needless to say, the development of an array of selective gene targeting vectors is vital for the future success of any therapeutic attempts aimed at protecting neurons in the diseased brains. 6, 16 Expression vectors with neuron-specific promoters have been constructed and used in the past to achieve gene expression selectively in neurons, such as the gene promoter of synapsin-1, [17] [18] [19] neuron-specific enolase (NSE), [20] [21] [22] tubulin-a promoter, 23 SCG10 24 and type II sodium channel. 25 The neuronal specificity of gene expression can also be determined by the presence and activities of the neuron restrictive silencer element (NRSE). NRSE is controlled by the neuron restrictive silencer factor (NRSF), which is only expressed in non-neuronal cells. 26, [26] [27] [28] [29] NRSEs have therefore been exploited to successfully mediate neuronspecific gene expression in combination with a heterologous promoter, for example, the phosphoglycerate kinase promoter 30, 31 when incorporated into the recombinant adenoviral vector. These vectors are effective in expressing genes constitutively in neurons.
However, it is often desirable in a therapeutic setting that the expression of the therapeutic gene is also in a regulated fashion, that is, gene expression is only turned on in response to a relevant pathological stimulus. Hypoxia responsive elements (HREs) have been used to construct inducible vectors to express therapeutic genes to treat cancer or cerebral ischemia. [32] [33] [34] For example, hypoxia-induced ischemic stroke to the brain rapidly activates hypoxia-inducible factor (HIF-1a), which in turn upregulates hypoxia-responsive genes through binding to the cis-acting HRE of target genes, [35] [36] [37] which include vascular endothelial growth factor (VEGF), glucose transporter-1, erythropoietin and the glycolytic enzymes. HIF-1 is a heterodimeric transcription factor consisting of HIF-1a and HIF-1b subunits and is required for regulation of O 2 homeostasis in tissues and cells. HIF1a expression and HIF-1 transcriptional activity increase exponentially as cellular O 2 concentration is reduced. HIF-1a is a short-lived protein that is rapidly degraded under normoxia by the ubiquitin-proteasome system. During hypoxia, HIF-1 degradation is blocked resulting in HIF-1a protein accumulation. 34, 37, 38 HREs have been shown to function as an effective enhancer of heterologous promoters such as the human CMV minimal promoter (CMVmp) and simian virus 40 minimal promoter. 32, [39] [40] [41] Five copies of HREs derived from the human VEGF gene were found to be optimal to mediate response to hypoxia in a vector. 40 A conatemer of nine copies of HREs isolated from the erythropoietin enhancer have also been successfully used in combination with simian virus 40 promoter to drive VEGF gene expression in the ischemic myocardium. 39 Taken together, we hypothesized that by combining optimal copy numbers of the enhancer/silencer elements HREs and NRSEs with CMVmp will produce an ideal gene expression vector, which is responsive to hypoxia and has gene expression restricted only to neurons. In this report, we demonstrate the construction of a replication defective adenoviral vector containing an optimized regulatory cassette, 5HRE-3NRSE and show that this recombinant adenovirus can mediate reporter gene expression selectively in mouse cerebellar granule neurons (CGNs) and differentiated human NT2 neurons in a hypoxia inducible manner.
Results
Construction and selection of neuron-selective and hypoxia-inducible gene expression vectors HRE sequence was selected from the human VEGF gene, 42 NRSE sequence was from human synapsin I gene, 31 while the CMVmp sequence was derived from human CMV IE promoter. Five copies of HRE (5HRE) and three to nine copies of NRSE (3-9NRSE), in various orientations and combinations as shown in Figure 1a , were subcloned into a plasmid vector upstream of the human CMVmp. Together these cassettes were then incorporated into the pShuttle transfer vector of the AdEasy vector system with luciferase gene product as a reporter. It was expected that constructs containing NRSE will not express the reporter gene in cells containing NRSF, such as non-neural 3T6 cells, but will express the reporter gene in cells without NRSF, such as neural PC12 cells and primary neurons. Nondifferentiated PC12 cells have been used as a reference neural cell line to study cis-acting NRSE activity, taking advantage of the lack of endogenous NRSF expression and activity. 18, 27, 31, 43 Indeed, RT-PCR demonstrated that NRSF mRNA expression was absent in PC12 cells, but present in 3T6 cells (Figure 1b) , confirming the utility of these two distinct cell types as screening tools for novel expression constructs.
To test whether these constructs selectively express genes in neurons under hypoxia, transient transfections were performed in undifferentiated neural PC12 and non-neural 3T6 cells using each of the constructs. After 24 h of transfection, the transfected cells were subjected The plasmid constructs were transfected into cultured PC12 and 3T6 cells. After 24 h of transfection, cells were either collected for luciferase assay (normorxia), or treated for 6 h under 1% oxygen (hypoxia). The vectors pCMVp, pCMVmp and p5HRE were used as controls. The fold of hypoxia induction in luciferase activity was calculated by dividing the luciferase activity after hypoxia with that obtained under normoxia. Asterisks indicate statistically significant difference with * indicating Pp0.05 and ** indicating Pp0.01 using the Student's t-test.
Hypoxia-inducible neuron-selective adenoviral vectors D Huang et al to 6 h hypoxia at 1% oxygen. Subsequently, luciferase activities were measured and the fold of induction in luciferase activity was calculated. As shown in Figure 1c , all constructs containing HRE and NRSE elements responded to hypoxia and exhibited significantly higher level of induction in luciferase activity in PC12 cells in comparison with that in 3T6 cells. In particular, the construct p5HRE-3NRSE showed a 12-fold induction in luciferase activity in PC12 cells, but did not show obvious luciferase induction in non-neural 3T6 cells ( Figure 1c ). Moreover, constructs with NRSEs downstream of 5HRE appeared to be more efficient in repressing luciferase expression in 3T6 cells under hypoxia than those constructs with NRSEs upstream of 5HRE. Three copies of NRSEs were also sufficient to mediate repression of gene expression in 3T6 cells ( Figure 1c and not shown). Control vectors without HRE and NRSE (labeled as pCMVp and pCMVmp in Figure 1a) showed extremely low response to hypoxia and no preference in the reporter gene expression in both PC12 and 3T6 cells ( Figure 1c ). Taken together, these experiments demonstrated that NRSE, together with HRE, can indeed modulate gene expression selectively in neural PC12 cells in response to hypoxia. As the construct p5HRE-3NRSE was very selective and effective in expressing the reporter gene in PC12 cells in response to hypoxia, the construct was chosen for further investigation.
Reduction in the basal CMVmp activity by the 5HRE-3NRSE regulator cassette
It is desirable in an inducible expression system to have low basal promoter activities prior to induction. To determine the basal promoter transcriptional activity of the construct p5HRE-3NRSE, we compared the expression of the reporter gene luciferase driven by p5HRE-3NRSE-CMVmp and a construct containing only the CMVmp. The CMVmp itself had extremely low transcriptional activities ( Figure 1c) . Interestingly, the construct p5HRE-3NRSE had significantly lower luciferase activity in comparison with the CMVmp construct, in that the basal CMVmp promoter activity was reduced by 95% in mouse 3T6 cells, 90% in mouse 3T3 L1 cells, 97% in human HT2 cells, 92% in HEK293 cells and 78% in rat NRK cells. The basal CMVmp activity of the 5HRE-3NRSE construct was also decreased by 50% in neural PC12 cells in comparison with that of the CMVmp construct. Taken together, these studies demonstrated that the construct 5HRE-3NRSE is an ideal inducible expression vector since it had extremely low leakiness in the transgene expression under both normoxia and hypoxia in non-neuronal cells.
Inducible gene expression of p5HRE-3NRSE in neuronal versus non-neuronal cell lines
To further characterize the neuronal-selective, hypoxiainducible gene expression of the p5HRE-3NRSE, several additional non-neuronal cell lines, including human HEK 293A, HT 29, rat NRK, mouse 3T3 L1 cells, were transfected with the construct p5HRE-3NRSE. As shown in Figure 2a , all of the non-neuronal cells had no induction in luciferase expression. In contrast, the activity of luciferase was induced more than 8.5-fold in PC12 cells, confirming neuron-selective and hypoxiainducible gene expression of the p5HRE-3NRSE construct.
The hypoxia-inducible expression of p5HRE-3NRSE in neural PC12 cells was also in a time-and oxygenconcentration-dependent manner (Figure 2b and c) . Under 1% oxygen, the level of luciferase activity peaked at 6 h hypoxia. The level reached a plateau between 9 Figure 2 Characterization of the construct p5HRE-3NRSE. (a) Hypoxiainducible expression of luciferase mediated by the construct p5HRE-3NRSE in human HEK 293A and HT 29 cells, rat NRK and PC12 cells, mouse 3T3 L1 and 3T6 cells. The vector p5HRE-3NRSE was transfected into the cultured cells and assayed for the reporter luciferase activity after 1% oxygen hypoxia for 6 h or under control normoxia. (b) Time-dependent hypoxia induction of luciferase activity in PC12 cells. The construct p5HRE-3NRSE and control pCMVmp were transfected into cultured cells, followed by treatment with 1% oxygen hypoxia. Temporal changes in luciferase activities following hypoxia were measured and plotted. Hypoxia induced reporter gene expression only in neural PC12 cells transfected with p5HRE-3NRSE, but not in non-neural3T6 cells. (c) Oxygenconcentration-dependent induction in the reporter gene expression. The construct p5HRE-3NRSE was transfected into PC12 and 3T6 cells followed by 6 h hypoxia under various oxygen concentrations as indicated. Luciferase activities were measured as described in the Method section. ** indicates statistical significance (Pp0.01) by Student's t-test.
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and 12 h and drastically decreased at 24 h. In contrast, no major induction in luciferase activities occurred in the non-neural 3T6 cells (Figure 2b ). The control vector pCMVmp without cis-HREs also showed no obvious luciferase induction in both cell types (Figure 2b ). Transfected cells were also cultured under a range of low oxygen conditions (from 0.1 to 5% oxygen) for 6 h. The construct p5HRE-3NRSE showed a robust upregulation of luciferase activities in PC12 cells, but not 3T6 cells (Figure 2c ). Specifically, luciferase activity increased up to 19-, 12-and two-fold in response to 0.1, 1 and 5% of oxygen levels, respectively. Little induction of luciferase (p1-fold) occurred under all levels of oxygen conditions in the non-neural3T6 cells (Figure 2c ). Taken together, these data strongly suggest that the construct p5HRE-3NRSE is an effective vector to target gene expression in neurons in a hypoxia-inducible manner.
Ad/5HRE-3NRSE-mediated gene expression in primary mouse CGNs and differentiated human NT2/Ns
In order to determine that the construct p5HRE-3NRSE can indeed selectively express transgenes in primary postmitotic neurons in an inducible manner, the 5HRE-3NRSE cassette was used as a regulatory element to generate a replication defective recombinant adenovirus driven by the CMVmp (Ad/5HRE-3NRSE). Postmitotic CGN cultures (containing more than 95% neurons) and cultured pure primary glial cells were infected with 200 multiplicity-of-infection (MOI) of Ad/5HRE-3NRSE particles for 24 h. The expression of luciferase was examined by luciferase activity assay or immunostaining with an antibody specific to luciferase. As shown in Figure 3a , hypoxia (1% oxygen for 6 h) induced an 11-fold increase in the luciferase activity in CGNs, but only a one-fold induction in glial cells. In contrast, the control adenovirus Ad/5HRE showed no cell type preference in luciferase induction with a close to a 40-fold increase in luciferase activity in both CGNs and glial cells ( Figure  3a) . Double-immunostaining was used to confirm that hypoxia-induced expression of luciferase through Ad/ 5HRE-3NRSE indeed occurred in neurons. As shown in Figure 3 (b-i), under normoxia, no luciferase staining could be detected in both glial (Figure 3b and c) and CGNs (Figure 3f-g ) infected either with Ad/5HRE or Ad/5HRE-3NRSE. Following 6 h hypoxia (1% oxygen), a clear induction of luciferase expression appeared in both pure glial cultures (Figure 3d ) and CGN cultures ( Figure  3h ) infected with the control Ad/5HRE. In contrast, only neurons in CGN culture infected with the Ad/5HRE-3HRSE vector (Figure 3i ), but not glial cells-infected with the same Ad/5HRE-3NRSE vector, had increased luciferase expression following hypoxia (Figure 3i ). The identity of neurons was confirmed by staining with neuron-specific marker such as Tau or MAP-2 (not shown) and the nuclei were highlighted by staining with Hoechst 32558 (Figure 3b-i) .
Differentiated human NT2 neurons (NT2/Ns) possess characteristics of fully developed neurons and have been used as a 'platform' for ex vivo gene therapies to treat a number of neurological disorders including stroke. 53, 54 Therefore, we investigate whether Ad/5HRE-3NRSE can mediate hypoxia-inducible gene expression selectively in differentiated human NT2/Ns. Indeed, following hypoxia, Ad/5HRE-3NRSE infected NT2/Ns cultures showed a 22-fold induction in the reporter luciferase activity after 1% O 2 hypoxia for 6 h. No significant induction of reporter activity occurred in cultured NT2 glial cells (Figure 4a ). Ad/5HRE infected NT2/Ns and NT2 glial cells all responded to hypoxia (40-fold in NT2/ Ns and 63-fold in NT2 glial cells, Figure 4a ). Consistently, using immunostaining techniques, no luciferase immunostaining was detected in either NT2/Ns or NT2 glial cells under normoxia when infected with either Ad/ 5HRE (Figure 4b) or Ad/5HRE-3NRSE (Figure 4c) . In NT2/Ns treated with hypoxia (1% oxygen hypoxia for 6 h), a clear immunostaining of luciferase expression was detected in both glial and differentiated neurons infected Figure 3 Hypoxia-inducible luciferase expression of Ad/5HRE-3NRSE in primary mouse CGNs. Primary mouse CGNs and pure glial cells growing in 24-well plates were infected with 200 MOI Ad/5HRE-3NRSE. After 24 h of infection, cells underwent 1% oxygen hypoxia for 6 h. Subsequently, cells were either lysed for lucifease activity assay (a), or fixed with formalin for immunostaining to detect luciferase expression in situ (b-i). Recombinant adenovirus Ad/5HRE, which responded to hypoxia in both neurons and non-neurons, was used as a vector control. In panels b-i, red color indicated luciferase staining, whereas blue color was from nuclear staining with Hoechst 32558. Solid arrows indicate glial cells, while empty arrows indicate neurons. Bars ¼ 100 mm.
with Ad/5HRE (Figure 4d ). In contrast, luciferase expression was only present in differentiated NT2 neurons, but not glial cells, under hypoxia in cultures infected with Ad/5HRE-3HRSE (Figure 4e ). Taken together, these studies demonstrated that the novel regulatory cassette 5HRE-3NRSE is effective in modulating hypoxia-inducible gene expression selectively in postmitotic neurons. Based on these results, we propose a working model to explain the concerted, yet differential actions of HREs and NRSEs on the CMVmp in different cell types in response to hypoxia ( Figure 5 ). Under normoxia, the NRSF binds to the NRSE element in non-neuronal cells, thereby inhibiting the basal transcriptional activity of the CMVmp. In neuronal cells, however, due to the lack of NRSF expression, the very low basal transcriptional activities derived from CMVmp are not inhibited. Following hypoxia, the presence of NRSF in nonneuronal cells may hinder the activities of hypoxiainduced HIF-1 to enhance CMVmp transcriptional activities. In contrast, the absence of NRSF in neurons allowed HIF-1 to effectively enhance the transcriptional machinery and thus gene expression in neurons.
Discussion
In this study, we report the successful construction of a novel adenoviral expression vector, which selectively expresses the reporter gene in postmitotic mouse and human neurons in a hypoxia-inducible manner. To the best of our knowledge, this is the first demonstration that such a combination of enhancer/silencer elements, that is HREs and NRSEs, can successfully modulate human CMVmp activity to selectively express genes in neurons in an inducible manner.
Two distinctive cell lines, that is PC12 and 3T6 cells, were employed as reference neurons and non-neuronal cells, respectively, for the initial screening and selection of plasmid constructs. Based on the cell type selectivity and the level of inducibility by hypoxia, the construct p5HRE-3NRSE-CMVmp was selected and used to generate a replication defective adenoviral vector Ad/ 5HRE-3NRSE-CMVmp. The resulting adenoviral vector Ad/5HRE-3NRSE was used to express the reporter gene in the postmitotic mouse CGNs and human NT2/Ns. Luciferase activity assay and immunocytochemical staining demonstrated that Ad/5HRE-3NRSE indeed exhibited the characteristics of expressing genes in a neuronselective and hypoxia-inducible manner. In addition, it is also important to note the following two additional interesting features of the 5HRE-3NRSE-CMVmp cassette. First, the basal promoter activity of CMVmp in non-neuronal cells was almost completely attenuated by the 5HRE-3NRSE cassette when inserted upstream of CMVmp. This unexpected inhibitory effect to the CMVmp activity was in fact advantageous to the specificity of the vector in that it resulted in the extremely low 'leaky' transgene expression in the nonneuronal cells both prior to and after hypoxia treatment. In neuronal cells, the 5HRE-3NRSE cassette also suppressed the CMVmp activity, albeit to a lesser extent, that is reduced by 50%. The residual CMVmp activity in Figure 4 Hypoxia-inducible luciferase expression of Ad/5HRE-3NRSE in human NT2Ns. NT2 glial cells and differentiated human NT2/Ns grown in 24-well plates were infected with 200 MOI Ad/5HRE-3NRSE. After 24 h of infection, cells were treated with hypoxia (1% oxygen) for 6 h. Subsequently, cells were either lysed for lucifease activity assay (a), or fixed with formalin for immunostaining to detect luciferase expression in situ (b-e). Recombinant adenovirus Ad/5HRE, which responded to hypoxia in both NT2/Ns and NT2 glial cells, was used as a vector control. In panels b to e, red color indicates luciferase staining, whereas blue color represents nuclear staining with Hoechst 32558. Solid arrows indicate glial cells, while empty arrows indicate neurons. Bars ¼ 100 mm. Hypoxia-inducible neuron-selective adenoviral vectors D Huang et al neurons may be regarded as very low level of 'leaky' expression. This very low leakiness of transgene expression in neurons is not expected to be a problem when the construct is used with an aim to selectively express genes in neurons. Second, the regulatory cassette of 5HRE-3NRSE demonstrated a clear oxygen concentration dependency in gene expression in neurons (Figure 2c) . Oxygen concentration at 1% was sufficient to induce a significant reporter gene expression in neurons. Further refinement of this oxygen concentration dependency may in the future lead to the design of a vector to express therapeutic genes at a physiological relevant level in neurons.
An HRE expression cassette derived from known hypoxia-regulated genes including NSE, lactate dehydrogenase, EPO, and PGK1 has been optimized and placed upstream of an SV40 minimal promoter controlling the expression of a luciferase reporter gene. 32, 33 Attempts have also been made in the past to construct hypoxia-inducible expression vectors using the HRE derived from the promoter of the hypoxia-inducible VEGF gene. [44] [45] [46] [47] The resulting hypoxia-inducible CMV promoter-driven bcl-2 expression vector conferred brain protection in a safe and lesion-selective manner in acute cerebral ischemia. 45 To achieve optimal response to hypoxia, Shibata et al 42 described the incorporation of five copies of the HRE elements derived from VEGF into the CMVmp-driven expression vector. The amount of gene expression of the vector had an excellent hypoxia/ aerobic ratio of approximately 100. In addition, when the plasmid vector 5HRE-hCMVmp was employed to drive the expression of the antiapoptotic bcl2 in hypoxic NT2N neurons -a cell culture model for ischemic neurons, albeit only a four-fold induction of transgene expression in NT2N cells, the expression of bcl2 was found to reduce significantly the number of apoptotic cells after hypoxia. 44 Therefore, multiple copies of HRE appeared to confer potent cellular response to hypoxia. The present study lends further support to the fact that five copies of HRE can mediate an oxygen dose-dependent response in gene expression.
Development of ideal viral vectors to express antiapoptotic factors in order to achieve neuroprotection is still in the early stages. 48 The strategy of restricting gene expression under the optimal regulation of five copies of HRE is now shown to be advantageous in comparison with the previous strategies to express genes driven by a single tissue-specific promoter. For example, NSE promoter-mediated gene expression, although relatively specific in neurons, the gene was still expressed in nonneuronal glial cells. 17 In contrast, our 5HRE-3NRSE construct not only showed significantly enhanced gene expression in neurons but also significantly inhibited the CMVmp activity in non-neuronal cells. Further refinement of this vector may lead to the development of optimal gene therapy vectors to investigate mechanisms of neuronal damage following ischemic stroke.
Materials and methods

Cell cultures
Human embryonic kidney 293A cells (HEK-293A) (Q BIOgene, Carlsbad, CA, USA), human colorectal adenocarcinoma HT-29 cells (ATCC HTB-38), rat kidney NRK cells (ATCC CRL-6509), mouse fibroblast 3T6 cells (ATCC CCL-96), mouse fibroblast 3T3-L1 cells (ATCC CL-173) were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal calf serum and 40 mg/ml gentamycin sulfate. Rat pheochromocytoma PC12 cells (ATCC CRL-1721) was cultured in DMEM supplemented with 10% horse serum, 5% fetal calf serum and 40 mg/ml gentamycin sulfate. Human embryonal teratocarcinoma Ntera2/D1 (NT2) cells (Stratagene, La Jolla, CA, USA) were cultured and differentiated into both glial cells and postmitotic neurons (NT2/Ns) as described previously. 55 Primary mouse CGNs were prepared from 6-9 day postnatal mice and cultured as described before. 49, 50 CGNs were cultured for 7-8 days before experimentation. Immunostaining of cultured CGNs with neuron-specific markers such as NeuN or MAP-2 confirmed that 95% of the cells were neurons. To obtain pure glial cells, cultured CGNs were treated with 120 mM glutamate for 24 h, which killed all neurons. After changing to fresh media, the remaining glial cells were cultured for an additional 2-3 weeks until the density of cells reached 80%.
Construction of plasmid vectors and production of recombinant adenoviruses
All vector constructs as illustrated in Figure 1a were generated by the following methods: (a) Vectors p5HRE-3NRSE, p5HRE-6NRSE and p5HRE-9NRSE(r) were constructed as follows: Double stranded (ds) oligonucleotide sequences encoding three copies of NRSEs were generated by annealing of the two synthetic complementary oligos (sense oligo, 5 0 -CTTTCAGCACCGCGGACAGTG CCTGCTTTCAGCACCGCGGACAGTGCCTGCTTTCAG CACCGCGGACAGTGCCTG-3 0 and the complimentary antisense oligo, 5 0 -CAGGCACTGTCCGCGGTGCTGAA AGCAGGCACTGTCCGCGGTGCTGAAAGCAGGCACT GTCCGCGGTGCTGAAAG-3 0 ). Two of these 3NRSE dsOligos were self-ligated to form 6NRSE, and three of these ds-oligos together formed the 9NRSE in either forward or inverted orientation (r). These ds-oligos were then subcloned into the BglII restriction site of the pGL3/ 5HRE-CMVmp-Luc vector (a gift from Dr Toru Shibata, Kyoto University, Japan) and sequenced to confirm the authenticity of the obtained recombinant plasmid vectors: that is, pGL3/5HRE-3NRSE-CMVmp-Luc, pGL3/ 5HRE-6NRSE-CMVmp-Luc and pGL3/5HRE-9NRSE(r)-CMVmp-Luc. These vectors were then digested with BamHI and KpnI, and the resulting fragments containing the expression cassettes were finally subcloned into the KpnI/EcoRV restriction sites of pShuttle transfer vector from the AdEasy vector system (Q BIOgene). (b) Vector p5HRE(r)-6NRSE(r) was derived from p5HRE-6NRSE by inverting the 5HRE-6NRSE cassette. The cassette 5HRE-6NRSE obtained from double-digestion of p5HRE-6NRSE with XbaI and BglII was blunt-ended and cloned into the EcoRV site of the pShuttle transfer vector in an inverted orientation. The fragment CMVmp-Luc obtained from double-digestion of pGL3/5HRE-CMVmpLuc with BglII and BamHI was then subcloned into HindIII site downstream of the 5HRE(r)-6NRSE(r) leading to the construction of p5HRE(r)-6NRSE(r)-CMVmpLuc vector. (c) To construct p3NRSE-5HRE and p6NRSE-5HRE, the plasmid vector pGL3/5HRE-CMVmp-Luc was cut with KpnI/BamHI to obtain the fragment Replication defective recombinant adenoviruses were generated from the constructed pShuttle transfer vectors using the AdEasy vector system (QBiogene), according to the manufacturer's instructions. The identity of all recombinant adenoviruses was confirmed by PCR amplification and luciferase activity assay of the reporter gene. Recombinant constructs were verified by sequencing and recombinant adenoviral particles were CsCl purified and titrated as described previously. 51 Plasmid transfection, adenoviral infection, hypoxia treatment and luciferase assay Plasmid DNAs were purified using a QIAGEN plasmid purification kit. In total, 1 mg DNA was used per transfection assay with the Lipofatamine 2000 transfection reagent (Invitrogen). Briefly, a day before transfection, cells were transferred into 12-well plates and grown in fresh medium to 60-70% confluency. Transfection in the presence of serum was performed following the manufacturer's instructions (Invitrogen). Cultured cells in 24-well plates were infected with the constructed adenoviral vectors at a 100-200 MOI as described previously. 51 One day after transfection or one day after Ad infection, cells were treated with hypoxia for 6 h. Cell lysate was collected for immediate luciferase activity assay. Luciferase activity was measured using the Bright-Glot Assay System (Promega) exactly following the manufacturer's instructions. The luciferase activity of each sample was normalized against the sample's protein concentration. At least four independent experiments were performed. The fold of hypoxia induction in luciferase activity was calculated by dividing the luciferase activity induced by hypoxia with that obtained under normoxia.
Immunocytochemical staining
Procedures for immunostaining was as described. 51 To detect luciferase expression, a primary goat polyclonal anti-lucifease antibody (Promega) was used at a dilution of 1:100. To detect neurons, rabbit polyclonal antibodies against tau and MAP2 (Sigma) were used at a dilution of 1:100 and 1:200, respectively. Appropriate secondary antibodies conjugated with either Cy-3 or FITC were used. Fluorescent images were examined and captured under a Zeiss AX10 Vert 200M fluorescent microscope.
RT-PCR assay
Total RNAs from PC12 and 3T6 cells were isolated with the TRIZOL Reagent (Invitrogen). The first-strand cDNAs were synthesized using a first-strand cDNA synthesis kit purchased from Amersham Biosciences. In total, 4 ml of the first-strand cDNA sample was used for PCR amplification of rat and mouse NRSF mRNA using the following specific primer pairs: rat NRSF mRNA, 5 0 -GAGATAGCCAGCTTCTGAAGGC-3 0 and 5 0 -GGTCACT TCCATCATGGCTGTG-3 0 ; mouse NRSF mRNA, 5 0 -GCT TGGTGCCTGTTAGAGACAG-3 0 and 5 0 -CTCCCTCAGTC ACTTT-ACCAGC-3 0 . b-Actin (5 0 -TCACCCACACTGTGC CCATCTACGA-3 0 ; 5 0 -CAGCGGAACCGCTC-ATTGCCA ATGG-3 0 ) was amplified as an internal control to normalize the target cDNA input. Optimal PCR thermal cycle condition was determined empirically and used as follows: 941C for 1 min, 601C for 1 min, 721C for 1 min. To detect NRSF, 35 cycles were used, while 25 cycles were used to linearly amplify b-actin. 
